| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 04/13/1994 | EP0591385A1 Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor |
| 04/13/1994 | EP0591316A1 Atp-dependent protease and use of inhibitors for same in the treatment of cachexia and muscle wasting |
| 04/13/1994 | EP0591165A1 Heterocyclic steroid compounds |
| 04/13/1994 | EP0446267B1 Hydroxamic acid based collagenase inhibitors |
| 04/13/1994 | CN1085082A Vitamin E drop |
| 04/13/1994 | CN1024198C Process for preparing adenosine derivatives |
| 04/12/1994 | US5302720 Biphenyl-substituted guanidine derivatives useful as hypoglycaemic agents |
| 04/12/1994 | CA1328452C Compounds |
| 04/12/1994 | CA1328409C Photoprotection compositions comprising tocopherol sorbate |
| 04/10/1994 | CA2108065A1 Antiarteriosclerosis agent and antihyperlipoproteinemics |
| 04/09/1994 | CA2107737A1 Therapeutical method for enhancing peripheral glucose utilization in a non-insulin-dependent diabetic patient |
| 04/06/1994 | EP0591057A1 Arylalkyl(thio)amides with melatonine receptor selectivity and process for their preparation |
| 04/06/1994 | EP0591046A1 Chromene derivatives with a triene chain for use in the treatment of osteoporosis inflammatory diseases |
| 04/06/1994 | EP0590793A1 Oxazolidine derivatives having anti-diabetic and anti-obesity properties, their preparation and their therapeutic uses |
| 04/06/1994 | EP0590563A1 Biotin amides, a process for their preparation and therapeutical compositions containing them as the active principles for the treatment of diabetes and relative complicating diseases |
| 04/06/1994 | EP0590309A2 Bone-related sulfatase-like protein and process for its production |
| 04/06/1994 | EP0590126A1 Polypeptides having kinase activity, their preparation and use |
| 04/06/1994 | EP0590094A1 4-aryl-3-(heteroarylureido)quinoline derivatives |
| 04/06/1994 | EP0589989A1 USE OF $g(b)-CELL TROPIN (ACTH 22-39) ANTAGONISTS IN THE TREATMENT OF HYPERINSULINAEMIA AND ASSOCIATED DISEASES |
| 04/06/1994 | EP0589874A1 (s)(+)-2-ethoxy-4- n- 1-(2-piperidinophenyl)-3-methyl-1-butyl]aminocarbonylmethyl]benzoic acid |
| 04/06/1994 | CN1084852A New acyclic amidine group-containing diphosphonic acid derivatives processes for the preparation thereof and pharmaceutical compositions containing them |
| 04/06/1994 | CN1084844A Methods for manufacturing mixtures of higher alphathic alcohols for pharmaceutical compositions |
| 04/05/1994 | US5300687 Trifluoromethylbenzylphosphonates useful in treating osteoporosis |
| 04/05/1994 | US5300639 2-oxo-3-carbonylamino-substituted azepine intermediates; lipoperoxide formation inhibitors |
| 04/05/1994 | US5300513 Vasopressin antagonists; vasodilators, hypotensive agents, water diuretics, and platelet agglutination inhibitors |
| 04/05/1994 | US5300496 Appetite suppressant |
| 04/05/1994 | US5300298 Methods of treating obesity with purine related compounds |
| 04/05/1994 | CA1328269C Intermediates and processes for the preparation of antihypercholesterolemic tetrazole compounds |
| 04/05/1994 | CA1328268C Antihypercholesterolemic tetrazole compounds |
| 04/05/1994 | CA1328265C Thiazolidinedione derivatives as hypoglycemic agents |
| 03/31/1994 | WO1994006750A1 Prostaglandin analog for treating osteoporosis |
| 03/31/1994 | WO1994006457A1 Pharmaceutical formulations of interleukin-1 inhibitors |
| 03/31/1994 | WO1994006417A1 Method of reducing blood levels of total cholesterol and low-density lipoprotein cholesterol |
| 03/31/1994 | WO1994006412A1 Sports drink without added sugar or artificial sweetener |
| 03/31/1994 | WO1994006310A1 Novel compositions |
| 03/31/1994 | WO1994006306A1 A process for producing beta-casein enriched products |
| 03/31/1994 | WO1994004122A3 Use of diacylglycerols for increasing the melanin content in melanocytes |
| 03/31/1994 | CA2144093A1 Prostaglandin analog for treating osteoporosis |
| 03/31/1994 | CA2144083A1 Aqueous composition for preparation of an optically clear product and process for preparation thereof |
| 03/31/1994 | CA2143333A1 Sports drink without added sugar or artificial sweetener |
| 03/30/1994 | EP0589488A1 (-)-Cimaterol and its use as a medicament or growth promoter |
| 03/30/1994 | EP0589473A1 Hydroxyphosphinyl phosphonate squalene synthetase inhibitors and their use in pharmaceutical compositions |
| 03/30/1994 | EP0589375A1 Micronutrient compositions |
| 03/30/1994 | EP0589018A1 Amines as inhibitors of squalene synthase |
| 03/30/1994 | EP0508993B1 Pharmaceutical compositions containing antigen-antibody complexes and uses therefor |
| 03/29/1994 | US5298627 Anticholesterol, hypolipidemic agents, enzyme inhibitors |
| 03/29/1994 | US5298495 Partricin derivatives |
| 03/29/1994 | CA2107180A1 Biotin amides, a process for their preparation and therapeutical compositions containing them as the active principles for the treatment of diabetes and relative complicating diseases |
| 03/26/1994 | CA2106716A1 Process for preparing 4-hydroxypyrrolo(2,3-d) pyrimidine based antifolate compounds and intermediates |
| 03/26/1994 | CA2104748A1 Hydroxyphosphinyl phosphonate squalene synthetase inhibitors and method |
| 03/23/1994 | EP0588539A1 Stabilized pharmaceutical compositions containing derivatives of vitamins D2 and D3 |
| 03/23/1994 | EP0588177A2 An interferon-alpha/beta binding protein, its preparation and pharmaceutical compositions containing it |
| 03/23/1994 | EP0588118A2 Bone-related carboxypeptidase-like protein and process for its production |
| 03/23/1994 | EP0587972A1 Sports drink without added sugar or artificial sweetener |
| 03/23/1994 | EP0587815A1 Hypertonic isochloremic formulation for circulatory shock |
| 03/23/1994 | EP0587771A1 Methods and compositions relating to genetically engineered cells that produce insulin in response to glucose |
| 03/23/1994 | EP0587711A1 Trace element-rich additive, method for preparing same, preparation in which the additive is included and use thereof |
| 03/23/1994 | EP0587670A1 Pcp receptor ligands and the use thereof |
| 03/23/1994 | EP0587577A1 Compounds and method for protection of cells and tissues from irreversible injury due to lactic acidosis |
| 03/23/1994 | EP0587555A1 A bifunctional dtpa-type ligand |
| 03/23/1994 | EP0443047B1 Liquid nutrient composition |
| 03/23/1994 | CN1084162A Octahydronaphthalene oxime derivatives for cholesterol biosynthesis inhibition, their preparation and use |
| 03/23/1994 | CN1084076A Fat-eliminating tincture |
| 03/22/1994 | US5296606 O-(3-amino-2-hydroxypropyl)-hydroximic acid halides and process for preparing the same |
| 03/22/1994 | US5296605 2,4-thiazolidinedione compounds |
| 03/22/1994 | US5296505 Reacting dithianepropenol with ethynyl-beta-ionol in presence of organomagnesium compound, hydrogenating triple bond, reducing diol with low-valency titanium |
| 03/22/1994 | US5296498 Guanidine compounds |
| 03/22/1994 | US5296481 Treatment process for promoting weight loss employing a substituted Δ5 |
| 03/22/1994 | US5296246 Active amino acid Ca, beverages containing same, and process for their production |
| 03/22/1994 | CA1327977C Method of preparing 1 .alpha.-hydroxyvitamin d and 1 .alpha.-hydroxy-previtamin d compounds, and adduct of a previtamin d or tachysterol compound with a suitable dienophile |
| 03/22/1994 | CA1327970C Isolation of castanospermine and its use as an antidiabetic agent |
| 03/17/1994 | WO1994005659A1 Substituted thiazolidinedione derivatives |
| 03/17/1994 | WO1994005634A1 Benzo-fused lactams promote release of growth hormone |
| 03/17/1994 | WO1994005630A1 1α,24(S)-DIHYDROXY VITAMIN D2, ITS FORMATION AND USE |
| 03/17/1994 | WO1994005317A1 Methods for treating renin-related disorders with amylin antagonists |
| 03/17/1994 | WO1994005297A1 Drugs containing diphosphonic acids and salts thereof |
| 03/17/1994 | WO1994005275A1 Method of preventing nmda receptor-mediated neuronal damage |
| 03/17/1994 | WO1994005274A1 Glycation inhibitor |
| 03/17/1994 | WO1993025568A3 Antihypercholesterolemic compounds and related pharmaceutical compositions and methods of use |
| 03/17/1994 | WO1993025530A3 Vinyl arenas having retinoid-like activity |
| 03/17/1994 | CA2273147A1 Substituted thiazolidinedione derivatives |
| 03/17/1994 | CA2143653A1 Methods for treating renin-related disorders with amylin antagonists |
| 03/16/1994 | EP0587499A1 Benzopyran compounds, process for their preparation and their use as cell protectors |
| 03/16/1994 | EP0587476A1 Compositions containing mono or polyhydroxylated amino acids for the treatment of non-insulin dependent diabetes mellitus |
| 03/16/1994 | EP0587473A1 Condensed pyridine derivatives as inhibitors of the effects of free radicals |
| 03/16/1994 | EP0587255A1 Insulinotropic hormone |
| 03/16/1994 | EP0587088A1 Derivatives of substituted cyclohexane, their process of preparation and their application with the treatment of diseases |
| 03/16/1994 | EP0587087A1 Substituted cyclohexane derivatives for the treatment of diseases |
| 03/16/1994 | EP0586960A1 Xanthone derivatives, their preparation and use |
| 03/16/1994 | EP0586806A1 Use of 2-(N-(2-aminoethyl)amino)acetic acid derivatives for the treatment of diseases which are mediated by non-enzymatical glycosylation |
| 03/16/1994 | EP0586592A1 Insulin and amylin containing composition for the treatment of insulin deficient mammals |
| 03/16/1994 | EP0586589A1 Treatment of anorexia and related states. |
| 03/16/1994 | EP0586537A1 Substituted n-carboxyalkylpeptidyl derivatives as antidegenerative active agents |
| 03/16/1994 | EP0586535A1 Methods and compositions based on inhibition of cell invasion and fibrosis by anionic polymers |
| 03/16/1994 | EP0586479A1 Dihydroxyindanone tyrosine kinase inhibitors |
| 03/16/1994 | CN1083704A Method of treatment of HIV-seropositive individuals with dietary whey proteins |
| 03/15/1994 | US5294724 4-hydroxytetrahydropyran-2-ones and the corresponding dihydroxycarboxylic acid derivatives, salts and esters and a process for their preparation |
| 03/15/1994 | US5294635 Heterocyclic compounds as aldose reductase inhibitors |
| 03/15/1994 | US5294634 Osteogenesis promoter |
| 03/15/1994 | US5294608 Guanidinoalkyl-1,1-bisphosphonic acid derivatives, process for their preparation and their use |